Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Journal of the European Academy of Dermatology and Venereology : JEADV|April 20, 2012
Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophyE Castela, E Archier, S Devaux, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2011
Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature reviewE Sbidian, A Maza, H Montaudié, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 20, 2012
Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalitiesE Castela, E Archier, S Devaux, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 20, 2012
Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic reviewS Devaux, A Castela, E Archier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 6, 2022
Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQR Curmin, S Guillo, Y De Rycke, et al.
The British Journal of Dermatology|September 7, 2018
Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trialsB E Strober, A B Gottlieb, P C M van de Kerkhof, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 17, 2019
Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQM Masson Regnault, J Castañeda-Sanabria, M H T Diep Tran, et al.
Autoimmunity Reviews|November 15, 2011
Hematological malignancy associated with polymyositis and dermatomyositisI Marie, L Guillevin, J-F Menard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 14, 2017
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohortE Sbidian, C Giboin, H Bachelez, et al.
Pageof 11